HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System
Abstract
Authors
P. Almeida M. Sebastião P. Ferreira T. Senna R.F. Alexandre